![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Supor Pharmaceuticals Co., Ltd. Shaoxing Cn, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Olanzapine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2019-182 - Rev 01
This Chemical Type CEP, issued on September 12, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2258 associated with this CEP further emphasizes